AbCellera Biologics Inc. (ABCL) [Rocket]

In millions, except per share items	Jun-30-23	Dec-31-22	Sep-30-22	Mar-31-22	Dec-31-21	Sep-30-21	Jun-30-21	Mar-31-21
	10-Q	10-K	8-K	10-Q	10-K	10-Q	10-Q	8-K/A
Assets
Current assets:
Cash and cash equivalents	179.7	386.5	372.0	545.7	476.1	517.7	792.6
Marketable securities	615.9	500.0		240.3	246.8	235.8
Total cash, cash equivalents, and marketable securities	795.7	886.5	868.2	786.1	723.0	753.5
Accounts and accrued receivable	45.7	38.6		334.4	160.6	43.6
Restricted cash	25.0	81.2	25.0	25.0	25.0
Other current assets	64.4	75.4	46.5	28.9	21.2	6.6	6.5
Total current assets	930.7	1,025.5	1,045.7	1,174.4	929.8	803.7	864.0

Long-term assets:
Property and equipment, net	259.6	217.3	200.6	122.0	111.6	91.6	87.5
Intangible assets, net	126.7	131.5	142.5	145.8	148.4	148.8	110.2
Goodwill	47.8	47.8	47.8	47.8	47.8	49.5	31.5
Investments in and loans to equity accounted investees	58.8	72.5		58.9	50.3	47.5	42.7
Other long-term assets	113.4	46.3	49.1	43.4	30.6	31.6	15.9

Total long-term assets
Total assets	1,537.2	1,540.9	1,552.4	1,592.3	1,318.6	1,172.7	1,151.9

Liabilities and shareholders' equity
Current liabilities:
Accounts payable and other liabilities	52.4	33.2		25.7	32.0	24.1	18.3
Contingent consideration payable	54.9	44.2		27.5	22.9	12.1	11.6
Accrued royalties payable	3.1	19.3		45.4	22.5	0.6	23.5
Deferred revenue	8.5	21.6		9.2	7.5	6.2	10.6
Total current liabilities	118.9	118.3	106.1	213.4	120.7	49.5	69.8

Long-term liabilities:
Operating lease liability	78.1	76.7		36.4	36.4	27.3	31.0
Deferred revenue	27.7	19.5			27.4
Deferred government contributions	76.4
Contingent consideration payable	5.8	16.1		30.6	35.9	44.9	9.6
Deferred tax liability	33.2	33.2	34.1	36.8	37.4	36.2	25.5
Other long-term liabilities	2.3	3.1	2.9	3.4	1.7	1.7	1.7
Total long-term liabilities	223.4	189.3	196.2	171.4	172.2	169.8	114.4
Total liabilities	342.3	307.6	302.2	384.8	292.8	219.3	184.2

Commitments and contingencies
Shareholders' equity:
Common shares: no par value	744.8	734.4		725.8	722.4	718.1	714.8
Additional paid-in capital	96.4	74.1	64.4	44.7	35.4	26.9	21.7
Accumulated other comprehensive (loss)	-1.9	-1.4	-0.7	0.8	0.3	0.6	2.2
Accumulated earnings	355.5	426.2	456.1	436.2	267.7	207.7	229.1
Total shareholders' equity	1,194.8	1,233.3	1,250.2	1,207.5	1,025.7	953.4	967.7
Total liabilities and shareholders' equity	1,537.2	1,540.9	1,552.4	1,592.3	1,318.6	1,172.7	1,151.9